Evaluation and management of obesity-related nonalcoholic fatty liver disease.
about
Tribbles-1: a novel regulator of hepatic lipid metabolism in humansStudying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiologyEpidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis.MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's diseaseNitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.Library of molecular associations: curating the complex molecular basis of liver diseases.Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitisGenome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.Transient elastography in chronic hepatitis B: an Asian perspective.Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance.Correlation of fatty liver and abdominal fat distribution using a simple fat computed tomography protocol.A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting.Brain metabolic dysfunction at the core of Alzheimer's disease.Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community.Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease.Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial.Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2.Effects of metabolic syndrome on fibrosis in chronic viral hepatitisEffect of body fat distribution on the transcription response to dietary fat interventions.Predictive factors for the development or regression of Fatty liver in Japanese adults.Targeting histone deacetylases for the treatment of diseaseThe efficacy and safety of traditional chinese medicine (jiang zhi granule) for nonalcoholic Fatty liver: a multicenter, randomized, placebo-controlled studyNonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes.Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers.A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma.Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis.A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study.Adipose tissue deficiency of hormone-sensitive lipase causes fatty liver in mice.APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice."Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population.Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study.Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders
P2860
Q26777717-5E10FDA5-B567-4639-B5E9-F8E09115597EQ27010291-9FECA092-4B07-49BB-9B52-9913FB2661E1Q30376120-7D1169F0-900C-44F9-9578-8FBB5ED6A340Q30439971-000F3EE1-52C0-46AA-926E-E56890350165Q30479198-3CB48C37-A17B-44E0-91D9-DBF2DCC444BFQ30484122-444C1AE8-5C5B-4A76-B67F-439A821EF677Q33543409-136E8129-A2D1-420A-90C2-D30D1FD7C8DFQ33944689-6AF142E4-6983-4031-8E77-08D2F35C94E4Q34224637-AED695A4-0708-43A6-AB70-687ABAF81FC9Q34284732-0E81CEE9-92A8-492C-A0B7-F75D42E76C3DQ34804886-982E31D4-DE35-4B23-B7E4-349F8DA2FC1FQ35177988-739EEDDB-F128-4986-9594-6D12D276937DQ35755173-03BF7335-8264-4D7F-9C6C-9DA5E25FAFCFQ35997881-C2AB5145-E63B-4CA0-915D-5EA71DFF054CQ36017421-63D9D440-0A49-4977-9A9A-096C7D6F58F5Q36623024-08A1E800-2737-40F1-8A1B-25D4B01E9C39Q36886508-6789BB3C-82FA-446A-9C28-6389836717F0Q36927013-389CDFC8-CA32-4085-BF17-31EA55EB8DC6Q37046576-79669261-D132-4EEC-8235-EF641EC11558Q37213139-610B614D-91AF-4DDC-8F51-402E40F6348EQ37246806-8478A9AB-C2D3-44FF-9D04-EF19D7EB262FQ37296159-38052DE6-A5CF-4C37-8D56-F8A535B12E71Q37402822-F3A8F1FE-133B-4795-84BA-E2BB78B9FB82Q37411158-3FF95F86-E353-47D7-836C-50843605EB44Q37602608-EB05E070-DE29-4700-A94E-98E7EBE82840Q37824721-37933337-1B62-43FA-AB9A-4F2776DA71BDQ43818911-A77296FD-8C81-4A25-AF98-FB1FA336FB73Q45805661-6D247690-3AC2-4FC7-8A86-E26FBF0EACE3Q46177222-79417C31-077C-498D-89FA-FAAB0D62885DQ46962933-A0741191-3317-4E8A-8537-850191F12E5AQ48132740-A1FD7F44-46C7-4BA2-81B6-5CCF13B77886Q51172839-B1157CF6-AA24-4E36-8EB7-7F4918AD048FQ53398091-4758E1C9-D034-4306-8349-C9AE29145E89Q54753378-E1D885FA-068B-4677-BFBC-A96B157E9C6CQ55526978-08C8A05A-661C-46C9-9782-C89B66D5AA71Q57191819-8173C93F-E8D0-4C81-9CCF-87B1025DFFD9
P2860
Evaluation and management of obesity-related nonalcoholic fatty liver disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Evaluation and management of obesity-related nonalcoholic fatty liver disease.
@en
type
label
Evaluation and management of obesity-related nonalcoholic fatty liver disease.
@en
prefLabel
Evaluation and management of obesity-related nonalcoholic fatty liver disease.
@en
P2860
P356
P1476
Evaluation and management of obesity-related nonalcoholic fatty liver disease.
@en
P2093
Clare Nugent
Zobair M Younossi
P2860
P2888
P304
P356
10.1038/NCPGASTHEP0879
P407
P577
2007-08-01T00:00:00Z